Stand Up To Cancer

A new study developed by the American Association for Cancer Research has found success with a stress-relief program that may increase the survival rate for women with recurrent breast cancer. Study author and psychology professor Barbara L. Andersen said that their findings, "show enduring benefits from the psychological intervention that were never previously considered or observed."
http://www.businessweek.com/lifestyle/content/healthday/639923.html

Cancer Research UK has found that a new drug called erlotinib (or Tarceva) may be able to extend life for women with advanced lung cancer, and is particularly helpful for those too ill to receive chemotherapy. While the study included 670 men and women, results were more positive for the latter. "These results are a real step forward in the search for an effective treatment for patients with advanced lung cancer," said Dr. Siow Ming Lee, trial leader and senior lecturer at the University College London Cancer Institute. "We are not yet sure why it was most effective in women but this is positive news for this large group who have few other treatment options."
http://news.bbc.co.uk/2/hi/health/10257084.stm

The National Cancer Institute recently awarded a $12.8 million grant to the Stanford University School of Medicine that will go towards integrated cancer research. Sylvia Plevritis, associate professor of radiology and director of the university's new center said, "Our work views cancer as a complex system. Instead of focusing on the function of one gene or protein, we want to identify a molecular network that captures interactions between many genes and proteins."
http://www.mercurynews.com/breaking-news/ci_15224449?nclick_check=1

St. Jude Children's Research Hospital may have found a way of identifying cancer survivors who are at an increased risk of developing more aggressive cancers later in life. Gregory Armstrong, M.D., assistant member of the St. Jude Department of Epidemiology and Cancer Control said, "These findings suggest non-melanoma skin cancers are a potential marker for survivors who are at risk for future invasive malignancies."
http://www.prnewswire.com/news-releases/non-melanoma-skin-cancer-may-help-identify-survivors-at-increased-risk-for-future-cancers-95769844.html

Please check back next Thursday for more news and helpful links!